Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Harjit Dumra, Arjun Khanna, Sujeet K Madhukar, Meena Lopez & Jaideep Gogtay. (2022) Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2277-2288.
Read now
Read now
Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Todd P Gilmer. (2019) Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1019-1031.
Read now
Read now
James F Donohue, Donald A Mahler & Sanjay Sethi. (2019) Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2947-2958.
Read now
Read now
Todd P. Gilmer, Bartolome R. Celli, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Maryam Navaie. (2019) Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease*. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 140-151.
Read now
Read now
Pierachille Santus, Dejan Radovanovic, Andrea Cristiano, Vincenzo Valenti & Maurizio Rizzi. (2017) Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease. Drug Design, Development and Therapy 11, pages 3257-3271.
Read now
Read now
Donald P Tashkin. (2016) A review of nebulized drug delivery in COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2585-2596.
Read now
Read now
Chris Garvey, Nicola A Hanania & Pablo Altman. (2014) Optimizing care of your patients with COPD. Nursing: Research and Reviews 4, pages 7-18.
Read now
Read now
Articles from other publishers (16)
Arjun Khanna, Pradeep Bajad, Sourabh Pahuja, Satyam Agarwal & Isham Goel. (2024) Analysis of Physician Prescription Patterns in Patients with Advanced Chronic Obstructive Pulmonary Disease. Indian Journal of Respiratory Care 12:4, pages 325-329.
Crossref
Crossref
Antonio AnzuetoIgor Z. BarjaktarevicThomas M. SilerTara RheaultThomas Bengtsson, Kathleen RickardFrank Sciurba. (2024)
Reply to Gan
et al.
, to Calzetta
et al.
, and to Poor
. American Journal of Respiratory and Critical Care Medicine 209:2, pages 226-228.
Crossref
Crossref
Amanda A. Foster, Jennifer Stoll, Christopher J. Daly, Collin M. Clark, Sanjay Sethi & David M. Jacobs. (2023) Patient and social factors related to nebulizer use in COPD patients at the transition of care: a qualitative study. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Maximillian H. Stevenson, Bridget McCrate Protus, Amanda G. LovellJunan LiMaureen L. Saphire. (2022) A Pharmacoeconomic Study of Respiratory Medications for Hospice Patients with End-Stage Respiratory Disease. Journal of Palliative Medicine 25:12, pages 1782-1789.
Crossref
Crossref
Deepak Talwar, R Ramanathan, Meena Lopez, Rashmi Hegde, Jaideep Gogtay & Geeta Goregaonkar. (2021) The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home. Lung India 38:2, pages 168.
Crossref
Crossref
Paul D. Terry & Rajiv Dhand. (2020) Maintenance Therapy with Nebulizers in Patients with Stable COPD: Need for Reevaluation. Pulmonary Therapy 6:2, pages 177-192.
Crossref
Crossref
Maryam Navaie, Carole Dembek, Soojin Cho-Reyes, Karen Yeh & Bartolome R Celli. (2020) Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis. Chronic Respiratory Disease 17, pages 147997311990123.
Crossref
Crossref
Allison Keshishian, Lin Xie, Carole Dembek & Huseyin Yuce. (2019) Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Clinical Therapeutics 41:11, pages 2283-2296.
Crossref
Crossref
Edward M. KerwinJames F. DonohueGary T. FergusonVaidyanathan GanapathyAyca Ozol-GodfreyKrithika Rajagopalan. (2019) Satisfaction with the Use of eFlow Closed-System Nebulizer in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: Findings from a Long-Term Safety Study. Journal of Aerosol Medicine and Pulmonary Drug Delivery 32:1, pages 24-33.
Crossref
Crossref
Ellen Ingrid Schafheutle, Tom Fegan & Darren M. Ashcroft. (2018) Exploring medicines management by COPD patients and their social networks after hospital discharge. International Journal of Clinical Pharmacy 40:5, pages 1019-1029.
Crossref
Crossref
Yuan Zhang, Rebecca L. Morgan, Pablo Alonso-Coello, Wojtek Wiercioch, Małgorzata M. Bała, Rafał R. Jaeschke, Krzysztof Styczeń, Hector Pardo-Hernandez, Anna Selva, Housne Ara Begum, Gian Paolo Morgano, Marcin Waligóra, Arnav Agarwal, Matthew Ventresca, Karolina Strzebońska, Mateusz T. Wasylewski, Lídia Blanco-Silvente, Janna-Lina Kerth, Mengxiao Wang, Yuqing Zhang, Saiprasad Narsingam, Yutong Fei, Gordon Guyatt & Holger J. Schünemann. (2018) A systematic review of how patients value COPD outcomes. European Respiratory Journal 52:1, pages 1800222.
Crossref
Crossref
Dean Quinn, Christopher N. Barnes, Wayne Yates, David L. Bourdet, Edmund J. Moran, Peter Potgieter, Andrew Nicholls, Brett Haumann & Dave Singh. (2018) Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies. Pulmonary Pharmacology & Therapeutics 48, pages 71-79.
Crossref
Crossref
Ignacio Aznar‐Lou, Ana Fernández, Montserrat Gil‐Girbau, Marta Fajó‐Pascual, Patricia Moreno‐Peral, María Teresa Peñarrubia‐María, Antoni Serrano‐Blanco, Albert Sánchez‐Niubó, María Antonia March‐Pujol, Anna Maria Jové & Maria Rubio‐Valera. (2017) Initial medication non‐adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients. British Journal of Clinical Pharmacology 83:6, pages 1328-1340.
Crossref
Crossref
Sharon R Rosenberg & Ravi Kalhan. (2017) Recent advances in the management of chronic obstructive pulmonary disease. F1000Research 6, pages 863.
Crossref
Crossref
James F. Donohue, Vaidyanathan Ganapathy, Vamsi Bollu, Michael D. Stensland & Lauren M. Nelson. (2017) Health Status of Patients with Moderate to Severe COPD after Treatment with Nebulized Arformoterol Tartrate or Placebo for 1 Year. Clinical Therapeutics 39:1, pages 66-74.
Crossref
Crossref
Bothaina Alhaddad, Kevin MG Taylor, Tricia Robertson, Geoffrey Watman & Felicity J Smith. (2016) Assistance of family carers for patients with COPD using nebulisers at home: a qualitative study. European Journal of Hospital Pharmacy 23:3, pages 156-160.
Crossref
Crossref